Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2023-10-24 00:00:00 ET · period of report 2023-10-20 · accession 0000950170-23-054850 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-24 | 2023-10-20 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.67 | +90.9K | 139.2K | +188% | +$60.9K |
| D | 2023-10-24 | 2023-10-20 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.00 | -90.9K | 60.0K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-20 | M | A | 90,900 | $0.67 | 139,150 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-10-20 | M | D | 90,900 | $0.00 | 60,005 | D | $0.67 · — to 2028-05-08 | 90,900 Common Stock | (F1) The shares subject to this stock option vested 25% on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter. |